Cargando…
Discovery of a selective TC-PTP degrader for cancer immunotherapy
T-cell protein tyrosine phosphatase (TC-PTP), encoded by PTPN2, has emerged as a promising target for cancer immunotherapy. TC-PTP deletion in B16 melanoma cells promotes tumor cell antigen presentation, while loss of TC-PTP in T-cells enhances T-cell receptor (TCR) signaling and stimulates cell pro...
Autores principales: | Miao, Jinmin, Dong, Jiajun, Miao, Yiming, Bai, Yunpeng, Qu, Zihan, Jassim, Brenson A., Huang, Bo, Nguyen, Quyen, Ma, Yuan, Murray, Allison A., Li, Jinyue, Low, Philip S., Zhang, Zhong-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646932/ https://www.ncbi.nlm.nih.gov/pubmed/38020389 http://dx.doi.org/10.1039/d3sc04541b |
Ejemplares similares
-
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity
por: Miao, Jinmin, et al.
Publicado: (2023) -
TC-PTP nuclear trafficking in keratinocytes
por: Kim, Mihwa, et al.
Publicado: (2017) -
Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling
por: Penafuerte, Claudia, et al.
Publicado: (2017) -
Overexpression of TC-PTP in murine epidermis attenuates skin tumor formation
por: Kim, Mihwa, et al.
Publicado: (2020) -
Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(1H)-Ones
por: Derkach, Kira V., et al.
Publicado: (2023)